Repeated Plasmapheresis of Blood Donors As a Source of Platelets

Author:

KLIMAN ALLAN12,GAYDOS LAWRENCE A.13,SCHROEDER LESLIE R.14,FREIREICH EMIL J.15

Affiliation:

1. Division of Biologics Standards and the National Cancer Institute, National Institutes of Health, Bethesda, Md.

2. Division of Biologics Standards, National Institutes of Health, Bethes&i, Md.

3. National Cancer institute, National Institutes of Health, Bethesda, Md.

4. National CanCer Institute, National Institutes of Health, Bethesda, Aid.

5. National Cancer lust itutes, National institutes of Health, Bethesda, Md.

Abstract

Abstract Repeated plasmapheresis with simple plastic equipment was performed on six normal donors for the purpose of obtaining platelet-rich-plasma. Plasmapheresis was performed at rates of up to 1000 ml. of plasma per week for periods up to three months. The six donors produced a total of 26.5 liters of platelet-rich-plasma, an amount which would have requried 106 separate blood donations had conventional means been used. No significant changes in hemoglobin, platelets or white cells were observed in the donors and serum protein depletion was minimal. No reactions to intensive plasmapheresis were encountered even when the procedure was abruptly terminated. Repeated donor plasmapheresis is a convenient method for producing large amounts of platelet-rich-plasma and affords a practical means of controlling donor factors in platelet transfusion studies.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility;Nature Communications;2024-03-22

2. Platelet storage: Progress so far;Journal of Thrombosis and Thrombolysis;2022-10-31

3. Novel blood derived hemostatic agents for bleeding therapy and prophylaxis;Current Opinion in Hematology;2022-08-03

4. PRP History;Platelet Rich Plasma in Medicine;2022

5. Production of Components by Apheresis;Transfusion Medicine;2021-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3